iGii welcomes new US Sales Director, Jason Diaz, to drive the US commercialisation of Gii Platform.

iGii is delighted to appoint Jason Diaz as US Sales Director.

Jason brings 15 years of experience in launching disruptive products to market into the human diagnostics and animal health markets successfully. His proven record, passion and drive in leading and building a high performing sales team in the diagnostics and sensing space has led to consistent successful product launch to markets, growth of revenue and business development opportunities.

Gii Platform is set to transform 5 key sensing markets. With customisable sensor options of the Gii Sens Biosensors range, powered by Gii – iGii’s pure 3D carbon nanomaterial with a large active surface area and innate antifouling properties offers a cost-effective, more sustainable, supply chain secure and scalable solution – and a compact handheld Bluetooth reader that can be connected to mobile devices, Gii Platform can be tailored to your needs with ultra-sensitive sensing for Point-of-Care Human and Veterinary Diagnostics, Environmental and Soil Monitoring and Food Safety applications.

Jason Diaz, iGii’s newly appointed US Sales Director

Jason will lead the establishment of iGii’s US presence by building upon existing commercial efforts within the US in 5 key markets. He will play an essential role to reinforcing the engagement and relationship development with existing and new customers to deliver the needs and the wants of our customers’ customer with Gii, Gii-Sens and Gii Platform.

Commenting on his appointment, Jason Diaz stated,

“Gii has the potential to become the go to material in sensing technology, addressing many pain points currently experienced. Our Sales and Product Development Teams have done a tremendous job introducing Gii to the markets, and I see immense opportunities. I am excited to position Gii as a disruptor across many diagnostic testing segments, while striving for a better, more sustainable, cost-effective testing alternative, where we can test when we need, where we need to improve outcomes for both our health and the environment.”

Jean-Christophe Granier, Chief Executive Officer at iGii added,

“Jason’s appointment demonstrates our commitment to grow and establish a world-class global team. His wealth of invaluable experience and knowledge of launching products to market and driving revenue growth will be a great asset to the team and strengthen our expansion to the US market.”